Kerala may soon enter a deal with the Russian Direct Investment Fund, the country’s sovereign wealth fund, to set up a unit for filling Sputnik V Covid-19 vaccine vials, news agency ANI reported. The RDIF has entered into a partnership with Dr Reddy’s Labs to market the first 250 million doses of Sputnik V in India. Kerala industries principal secretary …
Russia’s COVID-19 vaccine Sputnik V will be produced in India by generic pharmaceutical firm Hetero. Announcing an agreement with Hetero, sovereign wealth fund RDIF — which is piloting the vaccine — said more than 100 million doses of the vaccine would be produced. RDIF’s CEO Kirill Dmitriev said the agreement would pave the way for production of the ‘safe and …
Dr Reddy’s Laboratories Ltd could begin late-stage Indian clinical trials of Russia’s potential coronavirus vaccine in the next few weeks, an executive at the Indian drugmaker said on Tuesday. Indian trials of the Sputnik-V vaccine candidate, being developed by Russia’s sovereign wealth fund, will enroll 1,000-2,000 participants and be conducted at multiple government and private hospitals across the country, Deepak …
The Russian Direct Investment Fund on Wednesday said it will supply Dr. Reddy’s Laboratories with 100 million doses of the Sputnik-V Covid-19 vaccine for trial and distribution in India. The RDIF, which is Russia’s sovereign wealth fund, said it has agreed to cooperate with Dr.Reddy's Laboratories on clinical trials and distribution of the vaccine in India. "Upon regulatory approval in …
